Testicular Cancer and Fertility
Testicular cancer can affect fertility before treatment begins, and surgery, chemotherapy or radiotherapy can reduce sperm production further. Many men remain fertile after removal of one testicle, especially if the other testicle is healthy, but fertility cannot be assumed from normal erections, libido or testosterone. A semen analysis and discussion about sperm freezing should occur early when future biological children matter—ideally before chemotherapy or radiotherapy, and sometimes before orchidectomy if circumstances allow. Fertility preservation should not cause an unsafe delay in cancer treatment.
Why fertility may already be reduced
Testicular germ-cell cancer is associated with impaired sperm production in a substantial proportion of patients even before treatment. Previous undescended testis, testicular dysgenesis or problems in the opposite testicle may contribute.
Effect of orchidectomy
Removing one testicle decreases the amount of sperm-producing tissue, but the remaining testicle often compensates. If baseline sperm production is low, however, the reserve may be limited. Bilateral disease or treatment involving the only functioning testicle creates a much greater fertility issue.
Effect of chemotherapy and radiotherapy
Cisplatin-based chemotherapy can temporarily or sometimes persistently suppress sperm production; risk rises with cumulative treatment intensity. Radiotherapy near the remaining testicle can also impair spermatogenesis, even at relatively low scatter doses. Recovery can take months to years and is unpredictable.
Sperm banking
Cryopreservation is the standard fertility-preservation method for post-pubertal males who can provide a semen sample. Several samples may be stored if time allows. Even a low sperm count can be useful because assisted reproductive techniques such as ICSI require relatively few viable sperm.
After treatment: when to test fertility
A semen analysis can assess recovery after an appropriate interval. Conception timing after chemotherapy should be discussed with the oncology and fertility teams; recommendations depend on treatment and recovery. Testosterone symptoms should be assessed separately because fertility and testosterone production are related but not identical functions.
Fertility can be reduced before any treatment
Men with testicular cancer often have poorer semen parameters even before orchidectomy or chemotherapy. This may relate to testicular dysgenesis, tumour effects or baseline function of the opposite testis. A normal sexual drive or normal testosterone does not guarantee normal sperm production.
Treatment effects are different for surgery and chemotherapy
Removing one testicle usually leaves adequate fertility if the opposite testicle is healthy. Cisplatin-based chemotherapy can temporarily or permanently reduce sperm production depending on cumulative exposure and baseline reserve. Retroperitoneal lymph-node surgery can affect ejaculation if sympathetic nerves are damaged, although nerve-sparing techniques reduce this risk in suitable cases.
Do not self-start testosterone when trying for fertility
External testosterone can suppress pituitary gonadotropins and markedly reduce sperm production. Men concerned about fertility after cancer treatment should have semen analysis and hormone evaluation rather than using testosterone or unregulated “boosters” based only on symptoms.
Fertility is affected by the cancer as well as its treatment
Men with testicular cancer can have reduced sperm quality before any treatment, which is why a normal opposite testicle does not guarantee normal fertility. Orchidectomy, cisplatin-based chemotherapy, retroperitoneal surgery and radiotherapy have different effects on sperm production or ejaculation. Banking sperm before gonadotoxic treatment gives the greatest flexibility; after treatment, semen analysis is more informative than assuming fertility has or has not returned based on testosterone level or sexual function.
When to seek earlier medical review
Discuss fertility before gonadotoxic treatment whenever future biological children matter. After treatment, seek review for persistent infertility, loss of libido, erectile symptoms, hot flushes or other possible testosterone-deficiency symptoms rather than self-starting testosterone.
Emergency warning signs
- Sudden severe testicular pain, especially with nausea (torsion must be excluded urgently)
- Rapidly increasing scrotal swelling or severe pain
- Breathing difficulty, severe headache or neurological symptoms in a patient with known advanced cancer
- Fever or worsening wound redness after surgery
What to bring to your consultation
- Semen analysis or sperm-banking record
- Cancer pathology and planned treatment
- Hormone reports if done
- Partner fertility information only if already available/relevant
Questions to ask your doctor
- Should I bank sperm before chemotherapy or RPLND?
- When is semen analysis meaningful after treatment?
- Could testosterone therapy worsen fertility in my situation?
FAQs
If my testosterone is normal, is my fertility normal?
Not necessarily. Testosterone production and sperm production are different functions; semen analysis is needed to assess sperm.
Can sperm be frozen after orchidectomy?
Yes, often. The ideal timing depends on urgency and expected further treatment; banking should occur before chemotherapy when possible.
Does chemotherapy always cause permanent infertility?
No. Many men recover sperm production, but the timing and degree of recovery vary.
Can I father children naturally after testicular cancer?
Many survivors do. If semen quality remains low, fertility treatments may help, and banked sperm provides an additional option.
Related reading
- Testicular Cancer: Symptoms and Treatment
- Painless Testicular Lump: When to Worry
- Tumor Markers AFP, Beta-hCG and LDH Explained
- Radical Orchidectomy Explained
- Chemotherapy for Testicular Cancer
- Urologist in Latur
References
- European Association of Urology (EAU). Testicular Cancer Guidelines, 2026. Diagnostic Evaluation https://uroweb.org/guidelines/testicular-cancer/chapter/diagnostic-evaluation
- European Association of Urology (EAU). Testicular Cancer Guidelines, 2026. Disease Management https://uroweb.org/guidelines/testicular-cancer/chapter/disease-management
- European Association of Urology (EAU). Testicular Cancer Guidelines, 2026. Follow-up After Curative Therapy https://uroweb.org/guidelines/testicular-cancer/chapter/followup-after-curative-therapy
- National Cancer Institute. Testicular Cancer Treatment (PDQ) – Patient Version https://www.cancer.gov/types/testicular/patient/testicular-treatment-pdq
- ASCO. Fertility Preservation in People With Cancer: Guideline Update. Journal of Clinical Oncology. 2025 https://ascopubs.org/doi/10.1200/JCO-24-02782